Legal Representation
Attorney
Christina M. Licursi, Esq.
USPTO Deadlines
Next Deadline
1071 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20221129)
Due Date
November 29, 2028
Grace Period Ends
May 29, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 1, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 1, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 1, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 1, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 1, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Nov 29, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 29, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 27, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 26, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Oct 4, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 22, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 4, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 22, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 27, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 25, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 25, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 25, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 26, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 31, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 31, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 11, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 28, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 27, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 26, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 26, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 4, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 4, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 4, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jan 26, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 26, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 26, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 21, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 19, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 14, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids
First Use Anywhere:
20220800
First Use in Commerce:
20220800
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"EPIGENOMIC"